Detalles de la búsqueda
1.
Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
Catheter Cardiovasc Interv
; 99(6): 1839-1847, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312231
2.
Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
Catheter Cardiovasc Interv
; 98(7): 1393-1401, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34169643
3.
CT-Angiography to predict outcome after indirect mitral annuloplasty in patients with functional mitral regurgitation.
Catheter Cardiovasc Interv
; 97(3): 495-502, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602976
4.
BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
Catheter Cardiovasc Interv
; 98(1): E1-E8, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881396
5.
Management of Pulmonary Embolism: Results from the German Chest Pain Unit Registry.
Cardiology
; 146(3): 304-310, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33691308
6.
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project.
Eur Heart J
; 41(27): 2579-2588, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584388
7.
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Circulation
; 140(14): 1156-1169, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31510787
8.
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
Circulation
; 140(3): 240-261, 2019 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116032
9.
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Cardiovasc Diabetol
; 19(1): 179, 2020 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33066794
10.
The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
Catheter Cardiovasc Interv
; 95(6): 1076-1084, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31489742
11.
Transcatheter heart valve interventions: where are we? Where are we going?
Eur Heart J
; 40(5): 422-440, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30608523
12.
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Eur Heart J
; 40(31): 2632-2653, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116395
13.
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
Europace
; 21(2): 192-193, 2019 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052888
14.
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study.
Eur Heart J
; 39(15): 1295-1303, 2018 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29300869
15.
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
Eur Heart J
; 39(18): 1591-1601, 2018 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020259
16.
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III.
Catheter Cardiovasc Interv
; 92(7): E502-E511, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30079472
17.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
; 388(10059): 2479-2491, 2016 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806897
18.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
Lancet
; 387(10013): 31-9, 2016 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26470647
19.
Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients.
Eur Heart J
; 37(28): 2240-8, 2016 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190093
20.
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.
Eur Heart J
; 37(35): 2701-9, 2016 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190094